Lepu Biopharma Co. Ltd. Class H(HK:2157)
HK$2.80-0.12 (-4.11%)
HK:2157
Lepu Biopharma Co. Ltd. Class H ownership
HK$2.80
At close:-0.12 (-4.11%)
Want to see HK:2157 full AI Analyst Report?
Lepu Biopharma Co. Ltd. Class H (2157) Ownership - Who Owns Lepu Biopharma Co. Ltd. Class H?
4 Followers
Lepu Biopharma Co. Ltd. Class H (2157) Ownership Overview
- 0.06% Mutual Funds
- 1.51% ETFs
- 98.43% Public Companies and Individual Investors
The ownership structure of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is a mix of institutional, retail, and individual investors. Approximately 1.57% of the company’s stock is owned by Institutional Investors, and 98.43% is owned by Public Companies and Individual Investors.
The ownership structure of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is a mix of institutional, retail, and individual investors. Approximately 1.57% of the company’s stock is owned by Institutional Investors, and 98.43% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Ishares | 22,659,000 | Institution | 1.26% | 8,429,148 |
| State Street | 2,783,000 | Institution | 0.15% | 1,035,276 |
| Avantis | 729,000 | Institution | 0.04% | 271,188 |
| Fidelity Salem Street Trust | 666,000 | Institution | 0.04% | 247,752 |
| Spdr | 406,000 | Institution | 0.02% | 151,032 |
| Global X | 361,000 | Institution | 0.02% | 134,292 |
| State Street Institutional Investment Trust | 299,000 | Institution | 0.02% | 111,228 |
| Dimensional | 166,000 | Institution | <0.01% | 61,752 |
| American Century Etf Trust | 109,000 | Institution | <0.01% | 40,548 |
| Northern Trust | 45,000 | Institution | <0.01% | 16,740 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Salem Street Trust | 666,000 | Institution | 0.04% | 247,752 |
| State Street Institutional Investment Trust | 299,000 | Institution | 0.02% | 111,228 |
| American Century Etf Trust | 109,000 | Institution | <0.01% | 40,548 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares Core MSCI Emerging Markets ETF, IEMG ETF | 12,630,000 | Institution | 0.70% | 4,667,031 |
| SPDR Portfolio Emerging Markets ETF, SPEM ETF | 1,944,000 | Institution | 0.11% | 733,491 |
| SPDR S&P Emerging Markets Small Cap ETF, EWX ETF | 621,000 | Institution | 0.03% | 234,310 |
| Avantis Emerging Markets Equity ETF, AVEM ETF | 557,000 | Institution | 0.03% | 208,955 |
| iShares Core MSCI Total International Stock ETF, IXUS ETF | 482,000 | Institution | 0.03% | 178,108 |
| iShares MSCI EM IMI ESG Screened UCITS ETF, GB:SEDM ETF | 428,000 | Institution | 0.02% | 161,828 |
| Global X Aging Population ETF, AGNG ETF | 361,000 | Institution | 0.02% | 136,209 |
| iShares MSCI China Small-Cap ETF, ECNS ETF | 352,000 | Institution | 0.02% | 130,071 |
| iShr Core EmrgMktIMI, TSE:XEC ETF | 310,000 | Institution | 0.02% | 166,074 |
| iShares Core MSCI Emerging Markets IMI Index ETF Trust Units, TSE:XEC.U ETF | 310,000 | Institution | 0.02% | 166,074 |
FAQ
What percentage of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.57% of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is held by institutional investors: 0.06% by mutual funds and 1.51% by ETFs.
What percentage of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.43% of Lepu Biopharma Co. Ltd. Class H (HK:2157) stock is held by public companies and individual investors.
Who owns the most shares of Lepu Biopharma Co. Ltd. Class H (HK:2157)?
iShares owns the most shares of Lepu Biopharma Co. Ltd. Class H (HK:2157).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
